Avanos Medical (AVNS) Other financing activities (2013 - 2026)
Avanos Medical (AVNS) reported Other financing activities of $400000.0 for Q1 2026, little changed on a YoY basis from $400000.0 in Q1 2025, and up 33.33% sequentially from $300000.0 in Q3 2025.
Avanos Medical (AVNS) Other financing activities (2013 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 14 years of Other financing activities data on file, last reported at $400000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed 0.0% year-over-year to $400000.0; the trailing twelve-month figure through Mar 2026 stood at $700000.0 (down 30.0% YoY), and the FY2025 full-year result was $700000.0, down 36.36% from the prior year.
- Other financing activities climbed to $400000.0 in Q1 2026, from $300000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $900000.0 in Q3 2023 to a low of -$200000.0 in Q4 2023.
- A 5-year average of $433333.3 and a median of $450000.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 12.5% in 2023, while the deepest fall reached 300.0% in 2023.
- Tracing AVNS's Other financing activities over 5 years: stood at $100000.0 in 2022, then tumbled by 300.0% to -$200000.0 in 2023, then soared by 400.0% to $600000.0 in 2024, then tumbled by 50.0% to $300000.0 in 2025, then jumped by 33.33% to $400000.0 in 2026.
- Business Quant data shows AVNS's Other financing activities at $400000.0 in Q1 2026, $300000.0 in Q3 2025, and $400000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Mar 31, 2024 | 500,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 600,000.00 |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Sep 30, 2022 | 800,000.00 |